SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-18-241251
Filing Date
2018-08-07
Accepted
2018-08-07 16:51:58
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d372876ds3.htm S-3 317179
2 EX-4.3 d372876dex43.htm EX-4.3 316267
3 EX-4.5 d372876dex45.htm EX-4.5 107117
4 EX-4.6 d372876dex46.htm EX-4.6 107445
5 EX-4.7 d372876dex47.htm EX-4.7 94890
6 EX-5.1 d372876dex51.htm EX-5.1 24852
7 EX-23.1 d372876dex231.htm EX-23.1 1708
8 GRAPHIC g372876g97m83.jpg GRAPHIC 16028
9 GRAPHIC g372876snap0003.jpg GRAPHIC 9382
  Complete submission text file 0001193125-18-241251.txt   1005809
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-226652 | Film No.: 18998794
SIC: 2834 Pharmaceutical Preparations